Finding 975481 (2023-013)

Material Weakness
Requirement
B
Questioned Costs
$1
Year
2023
Accepted
2024-05-30
Audit: 307647
Organization: Wheeling Jesuit University INC (WV)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: Inadequate internal controls led to insufficient documentation for payroll and non-payroll expenditures charged to federal awards.
  • Impacted Requirements: Noncompliance with 2 CFR §200.430(i)(1)(i) regarding accurate records for salaries and wages and proper documentation for costs.
  • Recommended Follow-Up: Enhance internal controls to ensure accurate maintenance of time and effort records and retain documentation for all expenditures related to federal grants.

Finding Text

Finding 2023-013 – B. Allowable Costs/Cost Principles Information on Federal Program(s) – Research and Development Cluster (ALN 43.009, ALN 93.859) Criteria or Specific Requirement - 2 CFR §200.430(i)(1)(i) indicates that charges to Federal awards for salaries and wages must be based on records that accurately reflect the work performed. These records must be supported by a system of internal control which provides reasonable assurance that the charges are accurate, allowable, and properly allocated. Additionally, 2 CFR §200 requires that costs charged to programs are adequately documented. Condition – The summary level hourly documentation retained for payroll expenditures charged to the program was not formally supported with an adequate system of internal controls. Additionally, for certain non-payroll expenditures selected for testing, the University was unable to provide documentation adequately supporting the amount charged to the federal award. Cause - Administrative oversight and insufficient internal control. Effect or Potential Effect – Noncompliance with documentation of personnel expense standards. Questioned Costs – Below reportable threshold. Context – Context is as follows: Expenditures: For 2 of 2 months tested, the summary level hourly documentation retained was not formally supported with an adequate system of internal controls. Nonpayroll Expenditures: For 3 of 6 direct nonpayroll expenditures selected for testing, the University was unable to provide documentation adequately supporting the amount charged to the federal award. Indication of Repeat Finding - No similar findings noted in the prior year. Recommendation – We recommend that the University enhance its internal controls over compliance to ensure that time and effort records are appropriately maintained. Views of Responsible Officials – The University acknowledges that the records to substantiate the payroll and nonpayroll costs were insufficient and lacking internal controls. Going forward the University plans to implement a strategic process to document expenditures associated with research and development cluster and its federal grants. All employees that work with the Challenger Learning Center will continue to have their hours worked documented in the Paycom payroll software. Payroll is processed on a biweekly basis, and therefore on biweekly basis the payroll costs from the Challenger Learning Center will be reimbursed to the University from the various Challenger Learning Center bank accounts. This will be done as a percentage of time worked for the NIH Grant, the NASA Grant, and the general Challenger Learning Center functions. Additionally, for nonpayroll expenditures, all documentation will be retained to adequately support the amounts expended.

Categories

Questioned Costs Allowable Costs / Cost Principles Internal Control / Segregation of Duties

Other Findings in this Audit

  • 399013 2023-013
    Material Weakness
  • 399014 2023-014
    Material Weakness
  • 399015 2023-015
    Significant Deficiency
  • 399016 2023-009
    Significant Deficiency Repeat
  • 399017 2023-010
    Significant Deficiency
  • 399018 2023-016
    Significant Deficiency Repeat
  • 399019 2023-009
    Significant Deficiency Repeat
  • 399020 2023-010
    Significant Deficiency
  • 399021 2023-008
    Material Weakness
  • 399022 2023-010
    Significant Deficiency
  • 399023 2023-004
    -
  • 399024 2023-005
    Material Weakness Repeat
  • 399025 2023-009
    Significant Deficiency Repeat
  • 399026 2023-010
    Significant Deficiency
  • 399027 2023-016
    Significant Deficiency Repeat
  • 399028 2023-005
    Material Weakness Repeat
  • 399029 2023-006
    Material Weakness
  • 399030 2023-007
    Significant Deficiency Repeat
  • 399031 2023-009
    Significant Deficiency Repeat
  • 399032 2023-010
    Significant Deficiency
  • 399033 2023-016
    Significant Deficiency Repeat
  • 399034 2023-009
    Significant Deficiency Repeat
  • 399035 2023-010
    Significant Deficiency
  • 399036 2023-016
    Significant Deficiency Repeat
  • 399037 2023-011
    Significant Deficiency Repeat
  • 399038 2023-012
    Significant Deficiency Repeat
  • 399039 2023-013
    Material Weakness
  • 399040 2023-014
    Material Weakness
  • 975455 2023-013
    Material Weakness
  • 975456 2023-014
    Material Weakness
  • 975457 2023-015
    Significant Deficiency
  • 975458 2023-009
    Significant Deficiency Repeat
  • 975459 2023-010
    Significant Deficiency
  • 975460 2023-016
    Significant Deficiency Repeat
  • 975461 2023-009
    Significant Deficiency Repeat
  • 975462 2023-010
    Significant Deficiency
  • 975463 2023-008
    Material Weakness
  • 975464 2023-010
    Significant Deficiency
  • 975465 2023-004
    -
  • 975466 2023-005
    Material Weakness Repeat
  • 975467 2023-009
    Significant Deficiency Repeat
  • 975468 2023-010
    Significant Deficiency
  • 975469 2023-016
    Significant Deficiency Repeat
  • 975470 2023-005
    Material Weakness Repeat
  • 975471 2023-006
    Material Weakness
  • 975472 2023-007
    Significant Deficiency Repeat
  • 975473 2023-009
    Significant Deficiency Repeat
  • 975474 2023-010
    Significant Deficiency
  • 975475 2023-016
    Significant Deficiency Repeat
  • 975476 2023-009
    Significant Deficiency Repeat
  • 975477 2023-010
    Significant Deficiency
  • 975478 2023-016
    Significant Deficiency Repeat
  • 975479 2023-011
    Significant Deficiency Repeat
  • 975480 2023-012
    Significant Deficiency Repeat
  • 975482 2023-014
    Material Weakness

Programs in Audit

ALN Program Name Expenditures
84.268 Federal Direct Student Loans $6.40M
43.009 Cross Agency Support $2.30M
84.063 Federal Pell Grant Program $867,442
84.425 Education Stabilization Fund $486,600
93.859 Biomedical Research and Research Training $242,923
84.007 Federal Supplemental Educational Opportunity Grants $195,567
84.033 Federal Work-Study Program $75,998
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $9,430
84.038 Federal Perkins Loan Program $0